tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GYRE Stock Latest News

Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects
Company AnnouncementsGyre Therapeutics Faces Revenue Decline Amidst Future Prospects
15d ago
8K
GYRE
Five new option listings and option delistings on January 21st
PremiumThe Fly
Five new option listings and option delistings on January 21st
1M ago
SQ
ADN
Leadership Changes at Gyre Therapeutics Amid Strategic Shift
PremiumCompany Announcements
Leadership Changes at Gyre Therapeutics Amid Strategic Shift
2M ago
8K
GYRE
Gyre Therapeutics appoints Ping Zhang to board of directors
PremiumThe Fly
Gyre Therapeutics appoints Ping Zhang to board of directors
2M ago
GYRE
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
PremiumCompany Announcements
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
4M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
PremiumThe FlyGyre Therapeutics files $150M mixed securities shelf
4M ago
GYRE
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
Premium
The Fly
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
4M ago
GYRE
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
Premium
Company Announcements
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
7M ago
8K
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
7M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
7M ago
GYRE
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
PremiumCompany Announcements
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
8M ago
8K
GYRE
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
PremiumThe Fly
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
8M ago
GYRE
Gyre announces publication in Journal of Gastroenterology and Hepatology
PremiumThe FlyGyre announces publication in Journal of Gastroenterology and Hepatology
9M ago
GYRE
Gyre Therapeutics Advances with F230 IND Approval in China
Premium
Company Announcements
Gyre Therapeutics Advances with F230 IND Approval in China
9M ago
8K
GYRE
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
Premium
The Fly
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
9M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Gyre Therapeutics files $150M mixed securities shelf
9M ago
GYRE
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
PremiumThe Fly
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
9M ago
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
9M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
9M ago
GYRE
Gyre announces addition to Russell 2000 and 3000 Indexes
PremiumThe FlyGyre announces addition to Russell 2000 and 3000 Indexes
9M ago
GYRE
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
Premium
Company Announcements
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
10M ago
8K
GYRE
Gyre Therapeutics Welcomes New Expertise to Board Team
Premium
Company Announcements
Gyre Therapeutics Welcomes New Expertise to Board Team
12M ago
8K
GYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >